CoChat

Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials

Open access
Carlier, Pierre G., Marty, Benjamin, Scheidegger, Olivier, Loureiro de Sousa, Paulo, Baudin, Pierre-Yves, Snezhko, Eduard, Vlodavets, Dmitry · 2016 · Journal of Neuromuscular Diseases

The DOI matches its Crossref record; 293 of the 293 references it cites were found in a registry or an index.

Abstract

Recent years have seen tremendous progress towards therapy of many previously incurable neuromuscular diseases. This new context has acted as a driving force for the development of novel non-invasive outcome measures. These can be organized in three main categories: functional tools, fluid biomarkers and imagery. In the latest category, nuclear magnetic resonance imaging (NMRI) offers a considerable range of possibilities for the characterization of skeletal muscle composition, function and metabolism. Nowadays, three NMR outcome measures are frequently integrated in clinical research protocols. They are: 1/ the muscle cross sectional area or volume, 2/ the percentage of intramuscular fat and 3/ the muscle water T2, which quantity muscle trophicity, chronic fatty degenerative changes and oedema (or more broadly, “disease activity”), respectively. A fourth biomarker, the contractile tissue volume is easily derived from the first two ones. The fat fraction maps most often acquired with Dixon sequences have proven their capability to detect small changes in muscle composition and have repeatedly shown superior sensitivity over standard functional evaluation. This outcome measure will more than likely be the first of the series to be validated as an endpoint by regulatory agencies. The versatility of contrast generated by NMR has opened many additional possibilities for characterization of the skeletal muscle and will result in the proposal of more NMR biomarkers. Ultra-short TE (UTE) sequences, late gadolinium enhancement and NMR elastography are being investigated as candidates to evaluate skeletal muscle interstitial fibrosis. Many options exist to measure muscle perfusion and oxygenation by NMR. Diffusion NMR as well as texture analysis algorithms could generate complementary information on muscle organization at microscopic and mesoscopic scales, respectively. 31 P NMR spectroscopy is the reference technique to assess muscle energetics non-invasively during and after exercise. In dystrophic muscle, 31 P NMR spectrum at rest is profoundly perturbed, and several resonances inform on cell membrane integrity. Considerable efforts are being directed towards acceleration of image acquisitions using a variety of approaches, from the extraction of fat content and water T2 maps from one single acquisition to partial matrices acquisition schemes. Spectacular decreases in examination time are expected in the near future. They will reinforce the attractiveness of NMR outcome measures and will further facilitate their integration in clinical research trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3233/jnd-160145

Cites

293 of 293 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig.1 Skeletal muscle tissue characterization by NMR imaging. Comparison of qualitative and quantitative approaches. CSA: cross-sectional area; UTE: ultra-short echo time; DEMRI: delayed enhancement MRI; Fat Sat: fat saturation.
Fig.1 Skeletal muscle tissue characterization by NMR imaging. Comparison of qualitative and quantitative approaches. CSA: cross-sectional area; UTE: ultra-short echo time; DEMRI: delayed enhancement MRI; Fat Sat: fat saturation.CC BY-NC · PubMed Central
Fig.2 Failure of monoexponential fit of muscle T2 decay to distinguish between inflammatory and fatty degenerative changes. Both will result in an increased skeletal muscle global T2. To separate inflammation from fatty infiltration, specific sequences (with fat saturation) or processes (tri-exponential fit) need to be applied.
Fig.2 Failure of monoexponential fit of muscle T2 decay to distinguish between inflammatory and fatty degenerative changes. Both will result in an increased skeletal muscle global T2. To separate inflammation from fatty infiltration, specific sequences (with fat saturation) or processes (tri-exponential fit) need to be applied.CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 293 references

Research works printed but not linked: 2

  1. Rooney WD, Pollaro JR, Forbes SC, et al Application of the Extended Phas e Graph Technique to Improve T2 Quantitation Across Sites. 2011 In: Proceedings ISMRM 5419.
  2. Wary C, Azzabou N, Giraudeau C, et al Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. NMR Biomed. 2015 b; 28: 1150– 62. 26215733 · DOI

Cited by

Items 101–186 of 186

Metadata

Authors
Carlier, P. G., Marty, B., Scheidegger, O., Loureiro de Sousa, P., Baudin, P.-Y., Snezhko, E., & Vlodavets, D.
Affiliations
  • National Academy of Sciences of Belarus (BY)
  • Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
  • University of Bern (CH)
  • Strasbourg University, CNRS, ICube, Strasbourg, France
  • Consultants for Research in Imaging and Spectroscopy, Tournai, Belgium
  • N.I. Prirogov Russian National Medical Research University, Clinical Research Institute of Pediatrics, Moscow, Russian Federation
Corresponding author
Carlier, Pierre G.
Venue
Journal of Neuromuscular Diseases
Published
2016-03-03
Volume
3
Issue
1
Pages
1-28
ISSN
  • 2214-3599 (ISSN-L)
  • 2214-3602
OpenAlex
W2328069846
Cited by
186
References
292
Citations by year
2026: 8 · 2025: 19 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 34 · 2019: 25 · 2018: 8 · 2017: 7
FWCI
2.06
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuromuscular Diseases (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • HAL (submittedVersion, other-oa)
  • Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
  • Open Access CRIS of the University of Bern
Topics
  • Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Physical Sciences › Chemistry › Spectroscopy › NMR spectroscopy and applications
Keywords
skeletal muscle, NMR spectroscopy, clinical trial outcome measures, neuromuscular disorders, Dixon sequence, muscle cross-sectional area, 31P NMR, muscle energetics, late gadolinium enhancement, interstitial fibrosis, diffusion NMR, texture analysis, muscle blood flow, plasma membrane integrity
MeSH terms
Clinical Trials as Topic, Humans, Magnetic Resonance Imaging, Neuromuscular Diseases, Outcome Assessment, Health Care, Muscle, Skeletal

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.